on-randomized confirmatory study of dabigatran bridge therapy in perioperative period of ESD for gastric neoplasms in patients on anticoagulant - Dabigatran bridge therapy for gastric ESD

Cancer Institute Hospital0 个研究点目标入组 150 人开始时间: 2019年1月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1 Patients with non-valvular Af in CHADS2 score of 5 or 6 2 Have allergy for dabigatran 3 Have a plan to perform endoscopic resection for esophageal or duodenal lesion simultaneously 4 Had endoscopic treatment within 28 days from registration 5 Have infection requiring systemic treatments 6 Being or possible pregnant 7 Having psychiatric disorder and judged unsuitable for the clinical study. 8 Continuous systemic use of steroid 9 Using itraconazole which is contraindications of combination with dabigatran 10 Unstable angina (newly occurring or a worsening over the 3 weeks prior to ESD) or myocardial infarction within 6 months prior to ESD 11 Severe respiratory disease requiring continuous oxygen supply 12 Uncontrollable hypertension 13 Uncontrollable diabetes mellitus 14 Patients judged unsuitable for clinical study by investigators

发起方

Cancer Institute Hospital